We enrolled 92 unvaccinated HLA-DRB1*01:01+ COVID-19 patients, who were genotyped using PCR (Supplementary Figure 1) and divided into six groups, based on the level of severity of their COVID-19 symptoms (from severity 5 to severity 0, assessed at discharge). This evidence concerns the gene HLA-DRB1 and COVID-19.